2Marx J. New tumor suppressor may rival p53[J]. Science, 1994;264(5157):344-55.
3Tam SW, Shay JW, Pagano M.Differential expression and cell cycle regulation of the cyclin-dependent Kinase inhibitor p16[J]. Cancer Res, 1994;54(22):5816-20.
4Arap W, Nishikawa R, Furnari FB, et al . Replacement of the p16/CDKN2 gene suppresses human glioma cell growth[J]. Cancer Res, 1995;55(6):1351-4.
5Morgan RJ, Newcomb PV, Bailey M, et al . Loss of heterozygosity at microsatellite marker sites for tumor suppressor genes in esophageal adenocarcinoma[J]. Int J Surg Oncol, 1998;24(1):34-7.
7XU L,PIROLLO K F,CHANG E H.Tumor-targeted p53-gene therapy enhances the efficacy of conventional chemo/radiotherapy[J].J Control Release,2001,74(1-3):115-128.
8WEBER K J,WENZ F.p53,apoptosis and radiosensitivity--experimental and clinical data[J].Oncologie,2002,25(2):136-141.
9ABDULKARIM B,SABRI S,DEUTSCH E,et al.Antiviral agent Cidofovir restores p53 function and enhances the radiosensitivity in HPV-associated cancers[J].Oncogene,2002,21(15):2334-2346.
10KIM D H,KIM J S,JI Y I,et al.Hypermethylation of RASSF1A promoter is associated with the age at starting smoking and a poor prognosis in primary non-small cell lung cancer[J].Cancer Res,2003,63(13):3743-3746.
